FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2068185664> ?p ?o ?g. }

• W2068185664 endingPage "46" @default.
• W2068185664 startingPage "34" @default.
• W2068185664 abstract "Background: Osteoporosis and seizure disorders are common diagnoses in older adults and often occur concomitantly. Objective: The goal of this review was to discuss the current hypothesis for the pathogenesis of anticonvulsantinduced bone density loss and the evidence regarding the risk for osteoporosis and fractures in older individuals. Methods: A review of the literature was performed, searching in MEDLINE and CINAHL for articles published between 1990 and October 2009 with the following search terms: anticonvulsant OR antiepileptic; AND osteoporosis OR bone density OR fracture OR absorptiometry, photon. Studies within the pediatric population, cross-sectional studies, and studies whose results were published in a language other than English were excluded. Results: A search of the published literature yielded >300 results, of which 24 met the inclusion and exclusion criteria and were included in this review. Hepatic enzyme induction by certain anticonvulsant medications appears to contribute to increased metabolism of 25-hydroxyvitamin D to inactive metabolites, which results in metabolic bone disease. There is increasing evidence that anticonvulsant use is associated with a higher risk of osteoporosis and clinical fractures, especially among older agents such as phenobarbital, carbamazepine, phenytoin, and valproate. Several observational studies suggest a class effect among anticonvulsant agents, associated with clinically significant reductions in bone mineral density and fracture risk. The use of anticonvulsant medications increases the odds of fracture by 1.2 to 2.4 times. However, only 2 large-scale observational studies have specifically examined the risk among those aged >65 years. This review also identified a randomized controlled trial whose results suggest that supplementation with high-dose vitamin D may be associated with increased bone mineral density in patients taking anticonvulsant medications. However, no randomized controlled trials investigating therapeutic agents to prevent fracture in this population were identified. Consequently, there are no formal practice guidelines for the monitoring, prevention, and management of bone disease among those taking anticonvulsants. Conclusions: Observational studies suggest an association between use of anticonvulsant medications, reduced bone mineral density, and increased fracture risk. Randomized clinical trials are needed to guide the management of bone disease among those who use anticonvulsants." @default.
• W2068185664 created "2016-06-24" @default.
• W2068185664 creator A5004973724 @default.
• W2068185664 creator A5012729113 @default.
• W2068185664 creator A5062369315 @default.
• W2068185664 date "2010-02-01" @default.
• W2068185664 modified "2023-10-10" @default.
• W2068185664 title "A review of the effect of anticonvulsant medications on bone mineral density and fracture risk" @default.
• W2068185664 cites W11227157 @default.
• W2068185664 cites W1588404570 @default.
• W2068185664 cites W1895204750 @default.
• W2068185664 cites W1969836710 @default.
• W2068185664 cites W1971487180 @default.
• W2068185664 cites W1974655497 @default.
• W2068185664 cites W1979315780 @default.
• W2068185664 cites W1984554331 @default.
• W2068185664 cites W1986179533 @default.
• W2068185664 cites W1987446186 @default.
• W2068185664 cites W1987485489 @default.
• W2068185664 cites W1987491143 @default.
• W2068185664 cites W2006585716 @default.
• W2068185664 cites W2013765479 @default.
• W2068185664 cites W2019459243 @default.
• W2068185664 cites W2025190704 @default.
• W2068185664 cites W2025352603 @default.
• W2068185664 cites W2030535294 @default.
• W2068185664 cites W2032821264 @default.
• W2068185664 cites W2038631800 @default.
• W2068185664 cites W2038656059 @default.
• W2068185664 cites W2042484646 @default.
• W2068185664 cites W2042793281 @default.
• W2068185664 cites W2055491774 @default.
• W2068185664 cites W2061722523 @default.
• W2068185664 cites W2064217231 @default.
• W2068185664 cites W2064577764 @default.
• W2068185664 cites W2065199904 @default.
• W2068185664 cites W2065224313 @default.
• W2068185664 cites W2067586128 @default.
• W2068185664 cites W2068014643 @default.
• W2068185664 cites W2070853311 @default.
• W2068185664 cites W2070899148 @default.
• W2068185664 cites W2072522568 @default.
• W2068185664 cites W2082229075 @default.
• W2068185664 cites W2083520627 @default.
• W2068185664 cites W2086221746 @default.
• W2068185664 cites W2094074893 @default.
• W2068185664 cites W2095375833 @default.
• W2068185664 cites W2108063837 @default.
• W2068185664 cites W2114221312 @default.
• W2068185664 cites W2120053495 @default.
• W2068185664 cites W2123177504 @default.
• W2068185664 cites W2140527350 @default.
• W2068185664 cites W2144727632 @default.
• W2068185664 cites W2144917266 @default.
• W2068185664 cites W2148683493 @default.
• W2068185664 cites W2150386088 @default.
• W2068185664 cites W2154015838 @default.
• W2068185664 cites W2154310483 @default.
• W2068185664 cites W2160202028 @default.
• W2068185664 cites W2166513726 @default.
• W2068185664 cites W2167162287 @default.
• W2068185664 cites W2323830513 @default.
• W2068185664 cites W2331198595 @default.
• W2068185664 cites W2418912129 @default.
• W2068185664 cites W4211188014 @default.
• W2068185664 cites W4211243636 @default.
• W2068185664 cites W4230523829 @default.
• W2068185664 cites W4252035275 @default.
• W2068185664 doi "https://doi.org/10.1016/j.amjopharm.2010.02.003" @default.
• W2068185664 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3570810" @default.
• W2068185664 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20226391" @default.
• W2068185664 hasPublicationYear "2010" @default.
• W2068185664 type Work @default.
• W2068185664 sameAs 2068185664 @default.
• W2068185664 citedByCount "128" @default.
• W2068185664 countsByYear W20681856642012 @default.
• W2068185664 countsByYear W20681856642013 @default.
• W2068185664 countsByYear W20681856642014 @default.
• W2068185664 countsByYear W20681856642015 @default.
• W2068185664 countsByYear W20681856642016 @default.
• W2068185664 countsByYear W20681856642017 @default.
• W2068185664 countsByYear W20681856642018 @default.
• W2068185664 countsByYear W20681856642019 @default.
• W2068185664 countsByYear W20681856642020 @default.
• W2068185664 countsByYear W20681856642021 @default.
• W2068185664 countsByYear W20681856642022 @default.
• W2068185664 countsByYear W20681856642023 @default.
• W2068185664 crossrefType "journal-article" @default.
• W2068185664 hasAuthorship W2068185664A5004973724 @default.
• W2068185664 hasAuthorship W2068185664A5012729113 @default.
• W2068185664 hasAuthorship W2068185664A5062369315 @default.
• W2068185664 hasBestOaLocation W20681856642 @default.
• W2068185664 hasConcept C118552586 @default.
• W2068185664 hasConcept C126322002 @default.
• W2068185664 hasConcept C187212893 @default.
• W2068185664 hasConcept C23131810 @default.
• W2068185664 hasConcept C2775858608 @default.
• W2068185664 hasConcept C2776541429 @default.

• next